16β-[18F]fluoro-5α-dihydrotestosterone ([18F]FDHT) PET/CT was developed to assess the AR status in tumor lesions and showed a good correlation between tracer uptake and AR expression in biopsied tissues in several studies [54]. Here, AR is linked to neoplasm.